HER3, PI3K, and JAK2 pathway activation on reverse phase protein microarray (RPMA) in HER2-amplified residual disease (RD) refractory to preoperative chemotherapy plus trastuzumab (H), lapatinib (L), or both (HL).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 621-621
Author(s):  
Frankie Ann Holmes ◽  
Corinne Ramos ◽  
Nicholas N Hoke ◽  
Maren K. Levin ◽  
Virginia A. Espina ◽  
...  
Microarrays ◽  
2007 ◽  
pp. 363-374
Author(s):  
Yaping Zong ◽  
Shanshan Zhang ◽  
Huang-Tsu Chen ◽  
Yunfei Zong ◽  
Yaxian Shi

Microarrays ◽  
2007 ◽  
pp. 363-373 ◽  
Author(s):  
Yaping Zong ◽  
Shanshan Zhang ◽  
Huang-Tsu Chen ◽  
Yunfei Zong ◽  
Yaxian Shi

2011 ◽  
Vol 416 (2) ◽  
pp. 145-151 ◽  
Author(s):  
Marta Bally ◽  
Shahida Syed ◽  
Andreas Binkert ◽  
Ekkehard Kauffmann ◽  
Markus Ehrat ◽  
...  

2004 ◽  
Vol 84 (2) ◽  
pp. 235-244 ◽  
Author(s):  
Hongbin Zha ◽  
Mark Raffeld ◽  
Lu Charboneau ◽  
Stefania Pittaluga ◽  
Larry W Kwak ◽  
...  

Bioanalysis ◽  
2013 ◽  
Vol 5 (18) ◽  
pp. 2269-2275 ◽  
Author(s):  
Hongwu Du ◽  
Chuanbao Li ◽  
Haiming Jin ◽  
Guangyu Chen ◽  
Yiping Xun

Sign in / Sign up

Export Citation Format

Share Document